{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T02:17:08Z","timestamp":1698286628603},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1986,7,1]],"date-time":"1986-07-01T00:00:00Z","timestamp":520560000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch. Pharmacol."],"published-print":{"date-parts":[[1986,7]]},"DOI":"10.1007\/bf00512931","type":"journal-article","created":{"date-parts":[[2004,11,17]],"date-time":"2004-11-17T02:27:20Z","timestamp":1100658440000},"page":"205-218","source":"Crossref","is-referenced-by-count":14,"title":["Central dopaminergic properties of HW-165 and its enantiomers; Trans-octahydrobenzo(f)quinoline congeners of 3-PPP"],"prefix":"10.1007","volume":"333","author":[{"given":"Stephan","family":"Hjorth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kjell","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arvid","family":"Carlsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\ufffdkan","family":"Wikstr\ufffdm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bengt","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","unstructured":"Ahlenius S, Hillegaart V (1985) Involvement of extrapyramidal motor mechanisms in the suppression of locomotor activity by antipsychotic drugs: A comparison between the effects produced by pre- or post-synaptic inhibition of dopaminergic. neurotransmission. Pharmacol Biochem Behav (in press)","DOI":"10.1016\/0091-3057(86)90203-0"},{"key":"CR2","first-page":"429","volume-title":"Handbook of experimental pharmacology","author":"N-E And\u00e9n","year":"1980","unstructured":"And\u00e9n N-E (1980) Regulation of monoamine synthesis and utilization by receptors. In: Szekeres L (ed) Handbook of experimental pharmacology. Springer, Berlin Heidelberg New York, pp 429?462"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/BF00518475","volume":"321","author":"N-E And\u00e9n","year":"1982","unstructured":"And\u00e9n N-E, Golembiowska-Nikitin K, Thornstr\u00f6m U (1982) Selective stimulation of dopamine and noradrenaline autoreceptors by B-HT 920 and B-HT 933, respectively. Naunyn-Schmiedeberg's Arch Pharmacol 321:100?104","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF01252801","volume":"58","author":"N-E And\u00e9n","year":"1983","unstructured":"And\u00e9n N-E, Grabowska-And\u00e9n M, Liljenberg B (1983a) Demonstration of autoreceptors on dopamine neurons in different brain regions of rats treated with gamma-butyrolactone. J Neural Transm 58:143?152","journal-title":"J Neural Transm"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF00497662","volume":"323","author":"N-E And\u00e9n","year":"1983","unstructured":"And\u00e9n N-E, Grabowska-And\u00e9n M, Lindgren S, Thornstr\u00f6m U (1983b) Synthesis rate of dopamine: Difference between corpus striatum and limbic system as a possible explanation of variations in reactions to drugs. Naunyn-Schmiedeberg's Arch Pharmacol 323:193?198","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1600-0773.1983.tb01075.x","volume":"52","author":"N-E And\u00e9n","year":"1983","unstructured":"And\u00e9n N-E, Nilsson H, Ros E, Thornstr\u00f6m U (1983c) Effects of B-HT 920 and B-HT 93 on dopamine and noradrenaline autoreceptors in the rat brain. Acta Pharmacol Toxicol 52:51?56","journal-title":"Acta Pharmacol Toxicol"},{"issue":"Suppl. 1983","key":"CR7","first-page":"154","volume":"1","author":"N-E And\u00e9n","year":"1983","unstructured":"And\u00e9n N-E, Golembiowska-Nikitin K, Nilsson H, Ros E, Thornstr\u00f6m U (1983d) Effects of two azepine derivatives (B-HT 920 and B-HT 933) on pre- and postsynaptic dopamine receptors in the brain. Acta Pharm Suec (Suppl. 1983: 1): 154?164","journal-title":"Acta Pharm Suec"},{"key":"CR8","volume-title":"Structure and function of dopamine receptors","author":"J Arnt","year":"1985","unstructured":"Arnt J (1985) Behavioural studies of dopamine receptors: Evidence for regional selectivity and receptor multiplicity. In: Creese I, Fraser C (eds) Structure and function of dopamine receptors. Alan R Liss, New York, in press"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF01249094","volume":"60","author":"J Arnt","year":"1984","unstructured":"Arnt J, Hyttel J (1984) Postsynaptic dopamine agonistic effects of 3-PPP enantiomers revealed by bilateral 6-hydroxy-dopamine lesions and by chronic reserpine treatment in rats. J Neural Transm 60:205?223","journal-title":"J Neural Transm"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF00427262","volume":"81","author":"J Arnt","year":"1983","unstructured":"Arnt J, B\u00f6ges\u00f6 KP, Christensen AV, Hyttel J, Larsen J-J, Svendsen O (1983) Dopamine receptor agonistic and antagonistic effects of 3-PPP enantiomers. Psychopharmacology 81:199?207","journal-title":"Psychopharmacology"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF01249001","volume":"57","author":"A Carlsson","year":"1983","unstructured":"Carlsson A (1983) Dopamine receptor agonists: Intrinsic activity vs. state of the receptor. J Neural Transm 57:309?315","journal-title":"J Neural Transm"},{"key":"CR12","series-title":"Psychopharmacology","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-3-642-70140-5_4","volume-title":"Dyskinesia-research and treatment","author":"A Carlsson","year":"1985","unstructured":"Carlsson A (1985) Pharmacological properties of presynaptic dopamine receptor agonists. In: Casey DF, Chase TN, Christensen AV, Gerlach J (eds) Dyskinesia-research and treatment. Psychopharmacology, Suppl 2. Springer, Berlin Heidelberg New York Tokyo, pp 31?38"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.2042-7158.1973.tb09129.x","volume":"25","author":"A Carlsson","year":"1973","unstructured":"Carlsson A, Lindqvist M (1973) Effects of ethanol on the hydroxylation of tyrosine and tryptophan in rat brain in vivo. J Pharm Pharmacol 25:437?440","journal-title":"J Pharm Pharmacol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/0028-3908(83)90029-1","volume":"22","author":"LA Chiodo","year":"1983","unstructured":"Chiodo LA, Bunney BS (1983) Electrophysiological studies on EMD 23448, an indolyl-3-butylamine, in the rat: A putative selective dopamine autoreceptor agonist. Neuropharmacology 22:1087?1093","journal-title":"Neuropharmacology"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0014-2999(82)90297-7","volume":"83","author":"D Clark","year":"1982","unstructured":"Clark D, Carlsson A, Hjorth S, Svensson K, Engel J, Sanchez D (1982) Is 3-PPP a potential antipsychotic agent? Evidence from animal behavioural studies. Eur J Pharmacol 83:131?134","journal-title":"Eur J Pharmacol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/BF00439266","volume":"81","author":"D Clark","year":"1983","unstructured":"Clark D, Carlsson A, Hjorth S, Engel J, Lindberg P (1983a) The effect of the enantiomers of 3-PPP on conditioned avoidance in the rat. Psychopharmacology 81:14?17","journal-title":"Psychopharmacology"},{"issue":"Suppl 1983","key":"CR17","first-page":"145","volume":"1","author":"D Clark","year":"1983","unstructured":"Clark D, Carlsson A, Hjorth S, Svensson K, Liljequist S, Engel J, Engberg G, Svensson T, Wikstr\u00f6m H (1983b) Is 3-PPP a potential antipsychotic agent? Acta Pharm Suec (Suppl 1983: 1) pp 145?153","journal-title":"Acta Pharm Suec"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0014-2999(84)90694-0","volume":"106","author":"D Clark","year":"1984","unstructured":"Clark D, Hjorth S, Carlsson A (1984) (+)- and (?)-3-PPP exhibit different intrinsic activity at striatal dopamine autoreceptors controlling dopamine synthesis. Eur J Pharmacol 106:185?189","journal-title":"Eur J Pharmacol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/BF00496366","volume":"329","author":"D Clark","year":"1985","unstructured":"Clark D, Engberg G, Pileblad E, Svensson TH, Carlsson A, Freeman AS, Bunney BS (1985a) An electrophysiological analysis of the actions of the 3-PPP enantiomers on the nigrostriatal dopamine system. Naunyn-Schmiedeberg's Arch Pharmacol 329:344?354","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01260414","volume":"62","author":"D Clark","year":"1985","unstructured":"Clark D, Hjorth S, Carlsson A (1985b) Dopamine receptor agonists: Mechanisms underlying autoreceptor selectivity. I. Review of the evidence. J Neural Transm 62:1?52","journal-title":"J Neural Transm"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF01252236","volume":"62","author":"D Clark","year":"1985","unstructured":"Clark D, Hjorth S, Carlsson A (1985c) Dopamine receptor agonists: Mechanisms underlying autoreceptor selectivity. II. Theoretical considerations. J Neural Transm 62:171?207","journal-title":"J Neural Transm"},{"key":"CR22","first-page":"290","volume":"10","author":"GU Corsini","year":"1984","unstructured":"Corsini GU, Horowski R, Rainer E, Del Zompo M (1984) Treatment of Parkinson's disease with a dopamine partial agonist. Soc Neurosci Abstr 10:290 (Abstr no 88.6)","journal-title":"Soc Neurosci Abstr"},{"key":"CR23","first-page":"27","volume-title":"Apomorphine and other dopaminomimetics, vol 1, Basic Pharmacology","author":"VB Domesick","year":"1980","unstructured":"Domesick VB (1980) The anatomical basis for feedback and feedforward in the striatonigral system. In: Gessa GL, Corsini GU (eds) Apomorphine and other dopaminomimetics, vol 1, Basic Pharmacology. Raven Press, New York, pp 27?39"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0014-2999(83)90525-3","volume":"96","author":"E Eriksson","year":"1983","unstructured":"Eriksson E, Modigh K, Carlsson A, Wikstr\u00f6m H (1983) Dopamine receptors involved in prolactin secretion pharmacologically characterized by means of 3-PPP enantiomers. Eur J Pharmacol 96:29?36","journal-title":"Eur J Pharmacol"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/0024-3205(85)90154-7","volume":"36","author":"E Eriksson","year":"1985","unstructured":"Eriksson E, Svensson K, Clark D (1985) The putative dopamine autoreceptor agonist B-HT 920 decreases nigral dopamine cell firing rate and prolactin release in rat. Life Sci 36:1819?1827","journal-title":"Life Sci"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/0024-3205(83)90805-6","volume":"32","author":"MGP Feenstra","year":"1983","unstructured":"Feenstra MGP, Rollema H, Mulder TBA, Westerink BHC, Horn AS (1983) In vivo dopamine receptor binding studies with a non-radioactively labelled agonist, dipropyl-5,6-ADTN. Life Sci 32:1313?1323","journal-title":"Life Sci"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/j.1471-4159.1978.tb06573.x","volume":"31","author":"LJ Felice","year":"1978","unstructured":"Felice LJ, Felice JD, Kissinger PT (1978) Determination of catecholamines in rat brain parts by reverse-phase ion-pair liquid chromatography. J Neurochem 31:1461?1465","journal-title":"J Neurochem"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-1-4613-4042-3_3","volume-title":"Handbook of Psychopharmacology, vol 10","author":"S Fielding","year":"1978","unstructured":"Fielding S, Lal H (1978) Behavioural actions of neuroleptics. In: Iversen LL, Iversen SD, Snyder SH (eds) Handbook of Psychopharmacology, vol 10. Plenum Press. New York, pp 91?128"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/BF00498846","volume":"331","author":"CJ Fowler","year":"1985","unstructured":"Fowler CJ, Thorell G, Andersson M, Magnusson O (1985) Is inhibition of striatal synaptosomal tyrosine hydroxylation by dopamine agonists a measure of dopamine autoreceptor function? Naunyn-Schmiedeberg's Arch Pharmacol 331:12?19","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF00433091","volume":"69","author":"PJ Fray","year":"1980","unstructured":"Fray PJ, Sahakian BJ, Robbins TW, Koob GF, Iversen SD (1980) An observational method for quantifying the behavioural effects of dopamine agonists: Contrasting effects of d-amphetamine and apomorphine. Psychopharmacology 69:253?259","journal-title":"Psychopharmacology"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.2042-7158.1983.tb04834.x","volume":"35","author":"M Grabowska-And\u00e9n","year":"1983","unstructured":"Grabowska-And\u00e9n M, And\u00e9n N-E (1983) Stimulation of postsynaptic DA2 receptor produces jerks in reserpine-treated rats. J Pharm Pharmacol 35:543?545","journal-title":"J Pharm Pharmacol"},{"issue":"Suppl. 517","key":"CR32","first-page":"1","volume":"118","author":"S Hjorth","year":"1983","unstructured":"Hjorth S (1983) On the mode of action of 3-(3-hydroxyphenyl)-N-n-propylpiperidine, 3-PPP, and its enantiomers. Acta Physiol Scand (Suppl. 517) 118:1?52","journal-title":"Acta Physiol Scand"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF00428999","volume":"81","author":"S Hjorth","year":"1983","unstructured":"Hjorth S, Carlsson A, Clark D, Svensson K, Wikstr\u00f6m H, Sanchez D, Lindberg P, Hacksell U, Arvidsson L-E, Johansson A, Nilsson JLG (1983) Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP. Psychopharmacology 81:89?99","journal-title":"Psychopharmacology"},{"key":"CR34","unstructured":"Hjorth S, Svensson K, Carlsson A, Wikstr\u00f6m H, Andersson B, Sanchez D, Arvidsson L-E, Nilsson JLG, Johansson AM (1984a) Central dopaminergic properties of HW-165 and its enantiomers; trans-octahydrobenzo(f)quinoline congeners to 3-PPP. Presented at the VIIIth Int Symp on Med Chem, Uppsala, Sweden, Aug. 27?31, 1984. Proceedings, in press"},{"key":"CR35","first-page":"239","volume":"10","author":"S Hjorth","year":"1984","unstructured":"Hjorth S, Carlsson A, Clark D, Svensson K (1984b) Central dopaminergic actions of (+)- and (?)-3-PPP in relation to previous synaptic activity. Soc Neurosci Abstr 10:239","journal-title":"Soc Neurosci Abstr"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0024-3205(85)90435-7","volume":"37","author":"S Hjorth","year":"1985","unstructured":"Hjorth S, Clark D, Carlsson A (1985a) Lack of functional evidence for the involvement of sigma-opiate receptors in the actions of 3-PPP on central dopaminergic systems: Discrepancies between in vitro and in vivo findings. Life Sci 37:673?684","journal-title":"Life Sci"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF01256466","volume":"64","author":"S Hjorth","year":"1985","unstructured":"Hjorth S, Clark D, Svensson K, Carlsson A, Thorberg O (1985b) Subchronic administration of (?)-3-PPP and central dopamine receptor sensitivity changes. J Neural Transm 64:187?198","journal-title":"J Neural Transm"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0091-3057(86)90344-8","volume":"24","author":"S Hjorth","year":"1986","unstructured":"Hjorth S, Engel JA, Carlsson A (1986a) Anticonflict effect of low doses of the dopamine agonist apomorphine in the rat. Pharmacol Biochem Behav 24:237?240","journal-title":"Pharmacol Biochem Behav"},{"key":"CR39","doi-asserted-by":"crossref","unstructured":"Hjorth S, Eriksson E, Andersson B (1986b) Stereoselective inhibition of prolactin secretion by (?)-HW-165, a novel 3-PPP congener; further support for similarities between central dopamine autoreceptors and pituitary lactotroph dopamine receptors. Eur J Pharmacol (in press)","DOI":"10.1016\/0014-2999(86)90798-3"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1021\/jm00146a012","volume":"28","author":"AM Johansson","year":"1985","unstructured":"Johansson AM, Arvidsson L-E, Hacksell U, Nilsson JLG, Svensson K, Hjorth S, Clark D, Carlsson A, Sanchez D, Andersson B, Wikstr\u00f6m H (1985) Novel dopamine receptor agonists and antagonists with preferential action on autoreceptors. J Med Chem 28:1049?1053","journal-title":"J Med Chem"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF02205227","volume":"35","author":"W Kehr","year":"1974","unstructured":"Kehr W (1974) Temporal changes in catecholamine synthesis of rat forebrain structures after axotomy. J Neural Transm 35:307?317","journal-title":"J Neural Transm"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF00507343","volume":"293","author":"W Kehr","year":"1976","unstructured":"Kehr W (1976) 3-Methoxytyramine as an indicator of impulse-induced dopamine release in rat brain in vivo. Naunyn-Schmiedeberg's Arch Pharmacol 293:209?215","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1073\/pnas.81.15.4983","volume":"81","author":"BL Largent","year":"1984","unstructured":"Largent BL, Gundlach AL, Snyder SH (1984) Psychotomimetic opiate receptors labeled and visualized with (+)-(3H)3-(3-hydroxyphenyl)-N-(1-propyl)piperidine. Proc Natl Acad Sci USA 81:4983?4987","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR44","first-page":"99","volume":"96","author":"JT Litchfield Jr","year":"1949","unstructured":"Litchfield JT, Jr, Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96:99?113","journal-title":"J Pharmacol Exp Ther"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0378-4347(00)84308-X","volume":"221","author":"O Magnusson","year":"1980","unstructured":"Magnusson O, Nilsson LB, Westerlund D (1980) Simultaneous determination of dopamine, dopac and homovanillic acid. Direct injection of supernatants from brain homogenates in a liquid chromatography-electrochemical detection system. J Chromatogr 221:237?247","journal-title":"J Chromatogr"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF01253056","volume":"61","author":"GE Martin","year":"1985","unstructured":"Martin GE, Pettibone DJ (1985) Dopamine agonist activity of EMD 23,448. J Neural Transm 61:115?123","journal-title":"J Neural Transm"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/schbul\/6.3.456","volume":"6","author":"HY Meltzer","year":"1980","unstructured":"Meltzer HY (1980) Relevance of dopamine autoreceptors for psychiatry: Preclinical and clinical studies. Schizophrenia Bull 6:456?475","journal-title":"Schizophrenia Bull"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/BF00427264","volume":"81","author":"N Montanaro","year":"1983","unstructured":"Montanaro N, Vaccheri A, Dall'Olio R, Gandolfi O (1983) Time course of rat motility response to apomorphine: A simple model for studying preferential blockade of brain dopamine receptors mediating sedation. Psychopharmacology 81:214?219","journal-title":"Psychopharmacology"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0014-2999(76)90268-5","volume":"36","author":"RH Roth","year":"1976","unstructured":"Roth RH, Murrin LC, Walters J (1976) Central dopaminergic neurons: effects of alterations in impulse flow on the accumulation of dihydroxyphenylacetic acid. Eur J Pharmacol 36:163?171","journal-title":"Eur J Pharmacol"},{"issue":"Suppl 1983","key":"CR50","first-page":"243","volume":"2","author":"CA Seyfried","year":"1983","unstructured":"Seyfried CA, Fuxe K, Wolf H-P, Agnati LF (1983) Neurochemical and functional studies with EMD 23448, a novel dopamine agonist, Acta Pharm Suec (Suppl 1983: 2) pp 243?247","journal-title":"Acta Pharm Suec"},{"key":"CR51","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0378-4347(00)80425-9","volume":"228","author":"A Shum","year":"1982","unstructured":"Shum A, Sole MJ, van Loon GR (1982) Simultaneous measurement of 5-hydroxytryptophan and l-dihydroxyphenylalanine by high-performance liquid chomatography with electrochemical detection. Measurement of serotonin and catecholamine turnover in discrete brain regions. J Chromatogr 228:123?130","journal-title":"J Chromatogr"},{"key":"CR52","first-page":"1","volume":"Suppl 431","author":"U Str\u00f6mbom","year":"1975","unstructured":"Str\u00f6mbom U (1975) On the functional role of pre- and postsynaptic catecholamine receptors in brain. Acta Physiol Scand (Suppl 431): 1?43","journal-title":"Acta Physiol Scand"},{"key":"CR53","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF00428164","volume":"78","author":"UH Str\u00f6mbom","year":"1982","unstructured":"Str\u00f6mbom UH, Liedman B (1982) Role of dopaminergic neurotransmission in locomotor stimulation by dexamphetamine and ethanol. Psychopharmacology 78:271?276","journal-title":"Psychopharmacology"},{"key":"CR54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01249608","volume":"65","author":"K Svensson","year":"1986","unstructured":"Svensson K, Hjorth S, Clark D, Carlsson A, Wikstr\u00f6m H, Andersson B, Sanchez D, Johansson AM, Arvidsson L-E, Hacksell U, Wilsson JLG (1986) (+)-UH 232 and (+)-UH 242: Novel stereoselective dopamine receptor agonists with preferential action on autoreceptors. J Neural Transm 65:1?27","journal-title":"J Neural Transm"},{"key":"CR55","doi-asserted-by":"crossref","first-page":"5618","DOI":"10.1073\/pnas.81.17.5618","volume":"81","author":"SW Tam","year":"1984","unstructured":"Tam SW, Cook L (1984) ? opiates and certain antipsychotic drugs mutually inhibit (+)-(3H)SKF 10,047 and (3H)-haloperidol binding in guinea pig brain membranes. Proc Natl Acad Sci USA 81:5618?5621","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR56","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0014-2999(83)90091-2","volume":"87","author":"JC Oene Van","year":"1983","unstructured":"Van Oene JC, Houwing H, Dijkstra D, Horn AS (1983) trans-N-n-propyl-7-hydroxy-octahydrobenzo(f)quinoline, a rigid 3-PPP analogue with greater potency but lack of selectivity for dopamine autoreceptors. Eur J Pharmacol 87:491?495","journal-title":"Eur J Pharmacol"},{"issue":"Suppl","key":"CR57","first-page":"R80","volume":"325","author":"H Wachtel","year":"1984","unstructured":"Wachtel H, Rettig K-J, Seltz A (1984) The central dopamine agonistic action of transdihydrolisuride is unmasked at supersensitive receptors. Naunyn-Schmiedeberg's Arch Pharmacol (Suppl) 325:R80","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"CR58","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF00498834","volume":"296","author":"JR Walters","year":"1976","unstructured":"Walters JR, Roth RH (1976) Dopaminergic neurons: An in vivo system for measuring drug interactions with presynaptic receptors. Naunyn-Schmiedeberg's Arch Pharmacol 296:5?14","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"CR59","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0165-0173(81)90002-3","volume":"3","author":"RY Wang","year":"1981","unstructured":"Wang RY (1981a) Dopaminergic neurons in the rat ventral tegmental area. I. Identification and characterization. Brain Res Rev 3:123?140","journal-title":"Brain Res Rev"},{"key":"CR60","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0165-0173(81)90003-5","volume":"3","author":"RY Wang","year":"1981","unstructured":"Wang RY (1981b) Dopaminergic neurons in the rat ventral tegmental area. II. Evidence for autoregulation. Brain Res Rev 3:141?153","journal-title":"Brain Res Rev"},{"key":"CR61","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0197-0186(85)90108-1","volume":"7","author":"BHC Westerink","year":"1985","unstructured":"Westerink BHC (1985) Sequence and significance of dopamine metabolism in the rat brain. Neurochem Int 7:221?227","journal-title":"Neurochem Int"},{"key":"CR62","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1021\/jm00350a008","volume":"25","author":"H Wikstr\u00f6m","year":"1982","unstructured":"Wikstr\u00f6m H, Sanchez D, Lindberg P, Arvidsson L-E, Hacksell U, Johansson A, Nilsson JLG, Hjorth S, Carlsson A (1982) Monophenolic octahydrobenzo(f)quinolines: Central dopamine- and serotonin-receptor stimulating activity. J Med Chem 25:925?931","journal-title":"J Med Chem"},{"key":"CR63","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1021\/jm00374a016","volume":"27","author":"H Wikstr\u00f6m","year":"1984","unstructured":"Wikstr\u00f6m H, Sanchez D, Lindberg P, Hacksell U, Arvidsson L-E, Johansson A, Thorberg S-O, Nilsson JLG, Svensson K, Hjorth S, Clark D, Carlsson A (1984) Resolved 3-(3-hydroxyphenyl)-N-n-propylpiperidine and its analogues: Central dopamine receptor activity. J Med Chem 27:1030?1036","journal-title":"J Med Chem"},{"key":"CR64","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1021\/jm00380a012","volume":"28","author":"H Wikstr\u00f6m","year":"1985","unstructured":"Wikstr\u00f6m H, Andersson B, Sanchez D, Lindberg P, Arvidsson L-E, Johansson AM, Nilsson JLG, Svensson K, Hjorth S, Carlsson A (1985) Resolved monophenolic 2-aminotetralins and 1,2,3,4-4a,5,6,10b-octahydrobenzo(f)quinolines: Structural and stereochemical considerations for centrally acting pre- and postsynaptic dopamine-receptor agonists. J Med Chem 28:215?225","journal-title":"J Med Chem"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00512931.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00512931\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00512931","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T04:01:48Z","timestamp":1585972908000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00512931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,7]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1986,7]]}},"alternative-id":["BF00512931"],"URL":"https:\/\/doi.org\/10.1007\/bf00512931","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[1986,7]]}}}